ReviewRadiology. Imaging cancer2022
The Development of
Open access · diamondAbstract readReview
In one paragraph
Review in Radiology. Imaging cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 23 citations in OpenAlex.
- Synthesis and Characterization of Radio-Halogenated Talazoparib Analogues for Imaging and Radioligand Therapy.ACS chemical biology · 2026Article
- PARP‑1 in liver diseases: Molecular mechanisms, therapeutic potential and emerging clinical applications (Review).Molecular medicine reports · 2025Review
- Imaging poly(ADP-ribose) polymerase-1 (PARP1)Acta pharmaceutica Sinica. B · 2025Article
- Review
- [Communications medicine · 2025Article
- Preclinical evaluation of the potential PARP-imaging probe [carbonyl-EJNMMI radiopharmacy and chemistry · 2025Article
- Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-TargetedJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024Article
- [Journal of clinical medicine · 2024Review
- Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives.International journal of molecular sciences · 2024Review
- Poly(ADP-ribose) polymerase (PARP)-targeted PET imaging in non-oncology application: a pilot study in preclinical models of nonalcoholic steatohepatitis.American journal of nuclear medicine and molecular imaging · 2024Article
- Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023.Theranostics · 2024Review
- Poly (ADP-ribose) polymerases as PET imaging targets for central nervous system diseases.Frontiers in medicine · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 3 institutions in 1 country.
Hsiaoju S LeeFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).ORCID 0000-0001-9082-8618
Sally W SchwarzFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).
Erin K SchubertFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).
Delphine L ChenFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).
Robert K DootFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).ORCID 0000-0003-1747-239X
Mehran MakvandiFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).
Lilie L LinFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).
Elizabeth S McDonaldFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).ORCID 0000-0002-7209-4216
David A MankoffFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).ORCID 0000-0002-6971-5413
Robert H MachFrom the Department of Radiology, Perelman School of Medicine, University of Pennsylvania, 231 S 34th St, Vagelos Laboratories, Room 1012, Philadelphia, PA 19104-6323 (H.S.L., E.K.S., R.K.D., M.M., E.S.M., D.A.M., R.H.M.); Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, Mo (S.W.S.); Department of Radiology, University of Washington School of Medicine, Seattle, Wash (D.L.C.); and Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Tex (L.L.L.).ORCID 0000-0002-7645-2869
Mallinckrodt (United States) · USThe University of Texas MD Anderson Cancer Center · USUniversity of Washington · US
Funding
UNIVERSITY OF PENNSYLVANIA CAN CTR SUPPORT GRANTP30CA016520 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Robert H. Vonderheide · 1985 to 2026
$222.3MBreast Cancer PARP PET Imaging AIP to Support FDA Approval & CommercializationR01CA258717 · NCI · UNIVERSITY OF PENNSYLVANIA · PI LIN, LILIE LEMING, MANKOFF, DAVID A. · 2021 to 2025
$2.9MA novel PARP inhibitor PET tracer for breast cancerR01CA249329 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI LIN, LILIE LEMING, PIWNICA-WORMS, DAVID · 2021 to 2023
$748kNCI NIH HHS P30 CA016520NCI NIH HHS R01 CA249329NCI NIH HHS R01 CA258717
Abstract
Fluorine 18 (
Indexed as
Ovarian NeoplasmsPoly(ADP-ribose) Polymerase InhibitorsFemaleHumansMulticenter Studies as TopicPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) PolymerasesPositron-Emission TomographyUnited StatesPoly (ADP-Ribose) Polymerase-1Poly(ADP-ribose) Polymerase InhibitorsPoly(ADP-ribose) Polymerases18F-FTTBreastChemistryGenital/ReproductiveInvestigational New DrugMolecular Imaging-CancerPARPiPETRadiotracer Development
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.